Heart Failure Drugs Flashcards

1
Q

long term, this drug decreases myocardial fibrosis

A

spironolactone

eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

a prodrug, rapidly metabolized to active compound that reduces Na reabsorption

A

spironolactone

eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

spironolactone may cause hyperkalemia when combined with what drugs?

A

ace inhibitors

digoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

decreases mortality in CHF even at low doses that do not diurese

A

spironolactone

eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

side effect = gynecomastia

A

spironolactone

eplerenone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

decreases preload and afterload

A

captopril

enalapril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

side effect: angioedema, cough

A

captopril

enalapril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

which of these is a prodrug: captopril or enalapril

A

enalapril

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

protects against severe cardiac remodeling

A

ACEIs and ARBS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

toxic to fetus

A

ACEIs and ARBS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

bilateral renal artery stenosis is a contraindication

A

ACEIs and ARBS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

degrades ANP, BNP, CNP

A

Neprilysin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

enhances ARBs by blocking neprilysin and AT1 receptor

A

ARNI

Sacubitril/Valsartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

adverse effects: hypotension, angioedema, cough

A

Sacubitril/valsartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs that interact with ARNIs, causing angioedema

A

ACE inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

beta-1 selective blocker

A

metoprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

decreases after load, preload, heart rate, contractility, conduction velocity

A

beta blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

beta-nonspecific > alpha-1 blocker

A

carvedilol

19
Q

abrupt discontinuation of this drug may cause severe angina/MI

A

carbedilol

20
Q

use with caution in asthmatics

A

carvedilol

21
Q

contraindicated in decompensated CHF

A

beta blockers

22
Q

contraindicated in sick sinus syndrome and 2nd and 3rd degree AV block

A

beta blockers

ivabradine

23
Q

block adrenergic stimulated adverse remodeling of myocardium

A

beta blockers???

24
Q

if beta blockers combined with Ca channel blockers

A

severe hypotension

25
Q

hyperpolarization-activated cyclic nucleotide gated channel blocker
(the If channel on SA node)

A

ivabradine

26
Q

adverse effects of ivabradine

A

Afib
bradyarrythmias
visual disturbances

27
Q

metabolized by CYPs

A

ivabradine

28
Q

for what patient might you try ivabradine?

A

someone with stable, symptomatic CHF, EF <35%, HR>70, maxed out on beta-blockers

29
Q

unclear mechanism that dilates arterioles and decreases afterload

A

hydralazine

30
Q

improves morbidity and mortality in African Americans with CHF

A

BiDil (isosorbide denigrate + hydralazine)

31
Q

prodrug releases NO, causing vasodilation

veins (decrease preload)&raquo_space;> arteries (decrease after load)

A

isosorbide dinitrate

32
Q

need dose free period (14 h/d) to prevent tolerance

A

isosorbide dinitrate

33
Q

causes severe hypotension if combined with phosphodiesterase-5 inhibitors (Viagra)

A

isosorbide dinitrate

34
Q

contraindicated in CAD

A

hydralazine

35
Q

could enhance side effects of beta-blockers

A

hydralazine

36
Q

PDE-3 inhibitor

A

milrinone (IV)

37
Q

increases Ca+ to increase contractility

increases artery vasodilation to decrease afterload

A

milrinone (IV)

38
Q

short term (<48 h) use in acute decompensated HF

A

milrinone

39
Q

cardiac glycoside

A

digoxin

40
Q

inhibits Na/K ATPase pump to increase intracellular Ca+ in myocytes

A

digoxin

41
Q

increases vagal tone to decrease HR

A

digoxin

42
Q

risk of toxicity if combined with spironolactone

A

digoxin

43
Q

antibiotics increase bioavailability, and it has a low therapeutic index

A

digoxin

44
Q

indications: CHF, Afib

no mortality benefit

A

digoxin